PORTLAND, Ore., 24. April 2025 /PRNewswire/ -- Araceli Biosciences, ein wegweisendes Biotechnologieunternehmen, das die High-Content-Bildgebung und KI-gestützte Analyse revolutioniert, gab heute den erfolgreichen Abschluss seiner Seed-Finanzierungsrunde bekannt. Dabei wurden 7,2 Mio. USD...
Hence then, the article about araceli biosciences schliesst seed finanzierung in hohe von 11 2 mio usd ab um die geschwindigkeit der arzneimittelentwicklung zu beschleunigen was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Araceli Biosciences schließt Seed-Finanzierung in Höhe von 11,2 Mio. USD ab, um die Geschwindigkeit der Arzneimittelentwicklung zu beschleunigen )
Also on site :
- LG Display showcases wide lineup of world-first, leading OLED monitors
- Best Accounting Software for UK Small Business (January 2026): Sage Recognised as the Leading Solution for Managing Finances by Consumer365
- The Dollar Is Facing an End to Its Dominance